CLDN1 and cancer: Specifically, Claudin-1 expression has been associated with: (1) co-expression of SNAI2 and ZEB1 in hepatocellular carcinoma60, (2) EMT via the AMPK/TGF-β pathway in head and neck cancer61, and (3) cancer cell migration through partial EMT mechanisms62,63.